ClinicalTrials.gg
CompletedNCT07665411Updated Jun 24, 2026

Web-Based Resistance Training in Fibromyalgia

An interventional study of Web based resistance training in Fibromyalgia, sponsored by University of Beira Interior. Completed at 1 site in Portugal. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-06-24.

Sponsored by University of Beira Interior · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 years 3 months after the study started (first participant enrolled Feb 2023, registered Jun 2026).

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 14 studies in Fibromyalgia with a site in Portugal — 2 open to participants now, 2 under way, none of them phase 3. Fibromyalgia · Portugal.

Enrollment
13th of 13
13 · median 60
Started
2023
the only one that year
No phase
7 of 14
2 open now
Registered
13th of 14
by date
Lead sponsor
2 of 14
University of Beira Interior

Among the 14 studies in Fibromyalgia with a site in Portugal, this one is the 13th largest by enrollment of the 13 interventional ones that give a count, is the only one that started in 2023, is one of 7 with no phase, and was the 13th registered.

Fibromyalgia

1,245 studies on the registry are indexed under Fibromyalgia; 256 are open to participants now.

Browse Fibromyalgia studies →

Open to participants now

2 of the 14 studies in Fibromyalgia with a site in Portugal are open now. Recruiting first, the newest first:

All 2 open studies →

A study can be open while its sites in Portugal have not opened yet or have stopped. Only those recruiting at a site in Portugal →

Who these studies take

Of the 161 Fibromyalgia studies recruiting now, 51 (32%) set no upper age limit and 96 (60%) stop at 75 or younger; 15 take children under 18; 35 take healthy volunteers.

This study: 18 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 14 studies in Fibromyalgia with a site in Portugal, or all of them as a file.
02

Study summary

The purpose of this study is verify the effects of a 16 sessions of a web based resistance training, on balance, neuromuscular performance and symptomatology of fibromyalgia.

Read the detailed description

Volunteers who had been diagnosed with fibromyalgia were recruited and invited to participate in an sixteen sessions of a web-based resistance training programme, followed by a one-month detraining period. Before the intervention began, a face-to-face assessment was conducted to evaluate balance, neuromuscular performance, symptoms and the impact of fibromyalgia. The intervention involved two 50-minute sessions, followed by four weeks of detraining.

03

Conditions studied

  • Fibromyalgia

Browse trials for

Keywords

  • Resistance training
  • Fibromyalgia
  • web based
04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • medical diagnosis of fibromyalgia according to the American College of Rheumatology criteria
  • at least 18 years old

Exclusion criteria

Exclusion Criteria:

  • severe comorbidity or any other type of condition that negatively influences participation in the training program,;
  • cognitive disorders
  • heart problems
  • surgeries or fractures in the last 6 months
  • pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (actual)

Study arms

  • Experimental
    Web-based resistance training program

    Exercise

    Other: Web based resistance training

Interventions

  • OtherWeb based resistance training

    The web-based resistance training protocol was completed over the course of sixteen sessions, with each session lasting fifty minutes and occurring twice a week on alternate days.

06

What researchers measure

Primary outcomes

  1. Neuromuscular performance - Vertical jump

    A force platform is used to measure the vertical jump of the lower limbs. The greater the vertical jump height in centimeters, the better the performance is considered to be.

    Time frame: Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  2. Neuromuscular performance - Medicine ball throw

    The medicine ball throw test is used to assess neuromuscular performance of the upper limbs. The greater the distance in centimeters, the better the muscle performance is considered to be.

    Time frame: Baseline, after 8 weeks of intervention and after 4 weeks of detraining

Secondary outcomes

  1. Assessment of postural control based on the variable "Mean velocity of Center of Pressure (CoP)"

    The force plate is used to assess postural control with the eyes open and closed, during unipodal support and dual tasks (recalling a stressful day) tests. Increased velocity means (mm/s), means poorer postural control.

    Time frame: Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  2. Assessment of postural control based on the variable "95% confidence ellipse area"

    The force plate is used to assess postural control with the eyes open and closed, during unipodal support and dual tasks (recalling a stressful day) tests. The larger the area of the ellipse (mm2), the poorer the postural control.

    Time frame: Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  3. Fibromyalgia impact questionnaire

    Questionnaire to access information on the functional capacity and health status of individuals with fibromyalgia. It is composed of 20 questions. Values range from 0 to 100, with higher values indicating a greater impact of fibromyalgia.

    Time frame: Baseline, after 8 weeks and after 4 weeks of detraining

  4. Symptoms

    Visual Analogue Scale (VAS) to assess the intensity of pain, anxiety, quality of sleep, fatigue and mood state. The scoring range will be from 0 to 100, in which the higher the value, the greater the intensity.

    Time frame: Baseline, after 8 weeks of intervention and after 4 weeks of detraining

  5. The Short Falls Efficacy Scale International (Short FES-I)

    The questionnaire consists of seven questions related to concerns about falling during daily activities. Values range from a minimum of 7 (no concern about falling) to a maximum of 28 (severe concern about falling), and are categorised as low concern (7-8), moderate concern (9-13), and high concern (14-28).

    Time frame: Baseline, after 8weeks of intervention and after 4 weeks of detraining.

07

Study locations

1 site
  • University of Beira Interior
    Covilha, Castelo Branco District 6230-001, Portugal
08

References and documents

Individual participant data

Plan to share: No — In accordance with the Declaration of Helsinki, participant privacy and the confidentiality of personal information will be protected throughout the study. The informed consent obtained from participants does not include authorization for public sharing of individual-level data.

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Feb 2023 to primary completion in Aug 2024, 17 months.

Of 439 non-industry interventional studies with no phase under Fibromyalgia, half reached primary completion within 15 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 31. This study's 17 months is above that.

Counting every sponsor, half of 452 studies reached it within 15 months; a quarter within 6 and three quarters within 31.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 3, 2026
First posted
Jun 24, 2026
StartActual
Feb 13, 2023
Primary completionActual
Aug 9, 2024
CompletionActual
Aug 9, 2024
Last update
Jun 24, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Jun 24, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07665411
Lead sponsor
University of Beira Interior
Responsible party
Maria Luiza Laurentino de Albuquerque (Principal Investigator, University of Beira Interior) — Principal investigator
First posted
Jun 24, 2026
Start date
Feb 13, 2023
Primary completion
Aug 9, 2024
Completion
Aug 9, 2024
Last update
Jun 24, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Aug 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion